Zurich Cantonal Bank
IMVT icon

Zurich Cantonal Bank’s Immunovant IMVT Stock Holding History

Zurich Cantonal Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938K Buy
24,334
+504
+2% +$15.4K ﹤0.01% 1587
2026
Q1 		$592K Buy
23,830
+10,786
+83% +$279K ﹤0.01% 1753
2025
Q4 		$332K Hold
13,044
– – ﹤0.01% 2002
2025
Q3 		$210K Hold
13,044
– – ﹤0.01% 2169
2025
Q2 		$209K Hold
13,044
– – ﹤0.01% 2115
2025
Q1 		$223K Buy
13,044
+5,200
+66% +$109K ﹤0.01% 2044
2024
Q4 		$194K Sell
7,844
-81
-1% -$2.3K ﹤0.01% 2167
2024
Q3 		$226K Hold
7,925
– – ﹤0.01% 2039
2024
Q2 		$209K Sell
7,925
-5
-0.1% -$142 ﹤0.01% 2022
2024
Q1 		$256K Sell
7,930
-2,440
-24% -$89K ﹤0.01% 1910
2023
Q4 		$437K Buy
10,370
+951
+10% +$35K ﹤0.01% 1592
2023
Q3 		$362K Sell
9,419
-281
-3% -$6.35K ﹤0.01% 1598
2023
Q2 		$184K Buy
9,700
+3,780
+64% +$70.5K ﹤0.01% 1985
2023
Q1 		$91.8K Sell
5,920
-1,372
-19% -$23.8K ﹤0.01% 2332
2022
Q4 		$129K Sell
7,292
-784
-10% -$9.87K ﹤0.01% 2111
2022
Q3 		$45K Hold
8,076
– – ﹤0.01% 2626
2022
Q2 		$31K Hold
8,076
– – ﹤0.01% 2714
2022
Q1 		$44K Buy
8,076
+2,445
+43% +$15.2K ﹤0.01% 2550
2021
Q4 		$48K Sell
5,631
-120
-2% -$991 ﹤0.01% 2751
2021
Q3 		$50K Sell
5,751
-6
-0.1% -$54 ﹤0.01% 2612
2021
Q2 		$61K Buy
5,757
+52
+0.9% +$726 ﹤0.01% 2403
2021
Q1 		$92K Buy
5,705
+1,221
+27% +$32.2K ﹤0.01% 2187
2020
Q4 		$207K Buy
4,484
+928
+26% +$42.9K ﹤0.01% 1819
2020
Q3 		$125K Buy
+3,556
New +$107K ﹤0.01% 1881

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Zurich Cantonal Bank's IMVT Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Immunovant (IMVT) stake by 2.1% in Q2 2026, buying an estimated $15.4K and bringing the position to 24,334 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Zurich Cantonal Bank first reported a position in IMVT in Q3 2020 and has held it in 24 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Zurich Cantonal Bank held 24,334 shares of Immunovant worth $938K as of Q2 2026.
  • Zurich Cantonal Bank bought 504 Immunovant shares in Q2 2026, an estimated $15.4K.
  • Immunovant made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1587 holding.
  • Zurich Cantonal Bank first reported a position in Immunovant in Q3 2020 and has held it in 24 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.